The strategic truth behind Tobin’s cold chain acquisitions

Wed, Sep 10, 2025, 12:01 PM 3 min read

In the life sciences industry, the demand for precision-controlled logistics is surging. Biopharma innovation, the rise of cellular and gene therapies, and regulatory scrutiny require storage and transport solutions that guarantee temperature stability, whether in labs, manufacturing, or clinical supply chains. Facility expansions, infrastructure upgrades, and strategic acquisitions are becoming critical strategies for companies aiming to offer “gold standard” reliability and compliance across the cold chain ecosystem.

Recent industry movements from cold chain pharmaceutical companies emphasize major investments in temperature-controlled facilities, rapid regional expansion, and enhanced crisis resilience. Against this backdrop, Tobin Scientific’s recent announcements, including a new cGMP-compliant warehouse and a major acquisition, highlight how the company is evolving in lockstep with these pivotal supply chain trends.

In mid-July 2025, Tobin Scientific unveiled a new 40,000 sq ft cGMP-compliant warehouse in Wilmington, Massachusetts, just 20 miles north of Boston. The facility features dual –20 °C storage chambers built for full redundancy, high-density racking, validated ambient ranges (15–25 °C), and comprehensive backup power systems.

It marks Tobin’s third such facility in as many years, aligned with its $65 million growth capital raise earlier in 2025.

This expansion underscores a broader industry imperative: the need for geographically dispersed, high-integrity storage hubs. Such infrastructure enables responsiveness to R&D and supply-chain disruptions, supports scalability for biotech and pharma customers, and ensures compliance with standards like cGMP.

As Erik Groszyk, COO at Tobin Scientific, puts it, the company has “created a proven model for rapidly designing and deploying advanced warehouses that provide our clients with precision temperature control at unmatched value.”

Just weeks later, Tobin announced the acquisition of Wakefield Moving & Storage, a definitive deal adding 300,000 sq ft of warehouse space in New England. Wakefield brings deep expertise in lab relocations, sensitive equipment moves, and secure facility transitions. The acquisition notably broadens Tobin’s industry reach to sectors like semiconductors and defence, while strengthening core services in biotech, pharma, and academic research logistics.